In addition, treatment with an AhR inhibitor (10 μM) largely reversed the anti‐proliferative and antimigratory effects mediated by 3‐IAA in bladder cancer cells (Figure S5A–G, Supporting Information). Here, AHR is linked to urinary bladder carcinoma.